Technical Analysis for BLI - Berkeley Lights, Inc.

Grade Last Price % Change Price Change
F 21.42 -2.41% -0.53
BLI closed down 2.41 percent on Friday, September 24, 2021, on 1.25 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical BLI trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Older End-of-Day Signals for BLI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Berkeley Lights, Inc. Description

Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Oncology Stem Cells Cell Biology Application Software Automation Systems

Is BLI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 112.82
52 Week Low 19.211
Average Volume 1,567,598
200-Day Moving Average 54.60
50-Day Moving Average 37.89
20-Day Moving Average 31.01
10-Day Moving Average 26.05
Average True Range 2.62
ADX 44.74
+DI 8.29
-DI 42.92
Chandelier Exit (Long, 3 ATRs) 29.99
Chandelier Exit (Short, 3 ATRs) 27.07
Upper Bollinger Bands 42.52
Lower Bollinger Band 19.50
Percent B (%b) 0.08
BandWidth 74.23
MACD Line -4.44
MACD Signal Line -3.57
MACD Histogram -0.8657
Fundamentals Value
Market Cap 1.38 Billion
Num Shares 64.4 Million
EPS -99999.99
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 84.04
Price-to-Book 19.85
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.80
Resistance 3 (R3) 22.92 22.57 22.57
Resistance 2 (R2) 22.57 22.22 22.52 22.49
Resistance 1 (R1) 22.00 22.00 21.83 21.88 22.42
Pivot Point 21.65 21.65 21.57 21.60 21.65
Support 1 (S1) 21.08 21.30 20.91 20.96 20.42
Support 2 (S2) 20.73 21.08 20.68 20.35
Support 3 (S3) 20.16 20.73 20.27
Support 4 (S4) 20.04